456 related articles for article (PubMed ID: 16478824)
1. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
Morínigo R; Moizé V; Musri M; Lacy AM; Navarro S; Marín JL; Delgado S; Casamitjana R; Vidal J
J Clin Endocrinol Metab; 2006 May; 91(5):1735-40. PubMed ID: 16478824
[TBL] [Abstract][Full Text] [Related]
2. Postprandial changes in gut regulatory peptides in gastric bypass patients.
Holdstock C; Zethelius B; Sundbom M; Karlsson FA; Edén Engström B
Int J Obes (Lond); 2008 Nov; 32(11):1640-6. PubMed ID: 18794895
[TBL] [Abstract][Full Text] [Related]
3. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss.
Valderas JP; Irribarra V; Boza C; de la Cruz R; Liberona Y; Acosta AM; Yolito M; Maiz A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1069-75. PubMed ID: 20097707
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.
Korner J; Inabnet W; Conwell IM; Taveras C; Daud A; Olivero-Rivera L; Restuccia NL; Bessler M
Obesity (Silver Spring); 2006 Sep; 14(9):1553-61. PubMed ID: 17030966
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects.
Vidal J; Nicolau J; Romero F; Casamitjana R; Momblan D; Conget I; Morínigo R; Lacy AM
J Clin Endocrinol Metab; 2009 Mar; 94(3):884-91. PubMed ID: 19106269
[TBL] [Abstract][Full Text] [Related]
6. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
[TBL] [Abstract][Full Text] [Related]
7. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.
Korner J; Bessler M; Cirilo LJ; Conwell IM; Daud A; Restuccia NL; Wardlaw SL
J Clin Endocrinol Metab; 2005 Jan; 90(1):359-65. PubMed ID: 15483088
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.
Stock S; Leichner P; Wong AC; Ghatei MA; Kieffer TJ; Bloom SR; Chanoine JP
J Clin Endocrinol Metab; 2005 Apr; 90(4):2161-8. PubMed ID: 15657373
[TBL] [Abstract][Full Text] [Related]
9. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
10. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.
Rodieux F; Giusti V; D'Alessio DA; Suter M; Tappy L
Obesity (Silver Spring); 2008 Feb; 16(2):298-305. PubMed ID: 18239636
[TBL] [Abstract][Full Text] [Related]
11. Peptide YY levels are elevated after gastric bypass surgery.
Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
[TBL] [Abstract][Full Text] [Related]
12. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
[TBL] [Abstract][Full Text] [Related]
13. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.
Evans S; Pamuklar Z; Rosko J; Mahaney P; Jiang N; Park C; Torquati A
Surg Endosc; 2012 Apr; 26(4):1086-94. PubMed ID: 22044971
[TBL] [Abstract][Full Text] [Related]
14. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects.
Morínigo R; Vidal J; Lacy AM; Delgado S; Casamitjana R; Gomis R
Ann Surg; 2008 Feb; 247(2):270-5. PubMed ID: 18216532
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study.
Stratis C; Alexandrides T; Vagenas K; Kalfarentzos F
Obes Surg; 2006 Jun; 16(6):752-8. PubMed ID: 16756737
[TBL] [Abstract][Full Text] [Related]
16. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T
Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169
[TBL] [Abstract][Full Text] [Related]
17. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss.
Reinehr T; Roth CL; Schernthaner GH; Kopp HP; Kriwanek S; Schernthaner G
Obes Surg; 2007 Dec; 17(12):1571-7. PubMed ID: 18046613
[TBL] [Abstract][Full Text] [Related]
18. Fourteen weeks of treatment with Viscofiber increased fasting levels of glucagon-like peptide-1 and peptide-YY.
Greenway F; O'Neil CE; Stewart L; Rood J; Keenan M; Martin R
J Med Food; 2007 Dec; 10(4):720-4. PubMed ID: 18158848
[TBL] [Abstract][Full Text] [Related]
19. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial.
Chronaiou A; Tsoli M; Kehagias I; Leotsinidis M; Kalfarentzos F; Alexandrides TK
Obes Surg; 2012 Nov; 22(11):1761-70. PubMed ID: 22911148
[TBL] [Abstract][Full Text] [Related]
20. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects.
Romero F; Nicolau J; Flores L; Casamitjana R; Ibarzabal A; Lacy A; Vidal J
Surg Endosc; 2012 Aug; 26(8):2231-9. PubMed ID: 22302537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
